Acasti Pharma Inc (NAS:ACST)
$ 3.2256 -0.009 (-0.28%) Market Cap: 30.32 Mil Enterprise Value: 5.23 Mil PE Ratio: 0 PB Ratio: 0.47 GF Score: 41/100

Q1 2023 Acasti Pharma Inc Earnings Call Transcript

Aug 11, 2022 / 05:00PM GMT
Release Date Price: $5.4 (+1.35%)
Operator

Good day, and welcome to the Acasti Pharma First Quarter Fiscal Year 2023 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead.

Robert A. Blum
Lytham Partners, LLC - Managing Partner

Thank you very much, Rocco. Welcome to Acasti Pharma's First Quarter Fiscal 2023 Conference Call. On the call with us this afternoon is Jan D'Alvise, President and CEO; Brian Ford, Chief Financial Officer; Pierre Lemieux, Chief Operating and Scientific Officer; and Prashant Kohli, VP of Commercial Operations. Following management's prepared remarks, there will be a Q&A session. Should any questions remain after the call, please feel free to contact me at (602) 889-9700.

I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of the Canadian securities laws and forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot